who reports todayUS earnings, drawn as flowsMy portfolio

← Who reports today · Health Care

SOLV · Q2 2026

Archived report (Q2 2026). Latest deep dive →

US GAAP, Q2 2026 · quarter ended 06/30/2026 · released Aug 5

Net income

$92M

up 2.2% y/y

Total net sales

$2,209M

up 2.2% y/y

Operating income

$181M

down 15.4% y/y

Gross profit

$1,286M

up 9.4% y/y

The quarter in brief

Revenue grew 2.2% y⁠/⁠y to $2.21B, operating margin 8.2% vs 9.9%, net income $92M (+2.2% y⁠/⁠y).

All figures in $M.

Sankey diagram of SOLV earnings report for Q2 2026: revenue, costs and profitNet sales of product$1,698 · +1.8%Net sales of software andrentals$511 · +3.7%Total net sales$2,209 · +2.2%Cost of product$807 · −6.7%Cost of softwareand rentals$116 · −4.1%Gross profit$1,286 · +9.4%58.2% marginSelling, generalandadministrativeexpenses$927 · +20.1%Research anddevelopmentexpenses$178 · −5.8%Operating income$181 · −15.4%8.2% marginInterest expense,net$64 · −37.9%Other expense(income), net$9 · +12.5%Income beforeincome taxes$108 · +4.9%Provision for (benefitfrom) income taxes$15 · +15.4%13.9% effective rateNet income$92 · +2.2%$0.53/sh · 4.2% margin
Sankey diagram of SOLV earnings report for Q2 2026: revenue, costs and profit
Line itemAmount and change
Net sales of product$1,698 · +1.8%
Net sales of software and rentals$511 · +3.7%
Total net sales$2,209 · +2.2%
Cost of product$807 · −6.7%
Cost of software and rentals$116 · −4.1%
Gross profit$1,286 · +9.4% · 58.2% margin
Selling, general and administrative expenses$927 · +20.1%
Research and development expenses$178 · −5.8%
Operating income$181 · −15.4% · 8.2% margin
Interest expense, net$64 · −37.9%
Other expense (income), net$9 · +12.5%
Income before income taxes$108 · +4.9%
Provision for (benefit from) income taxes$15 · +15.4% · 13.9% effective rate
Net income$92 · +2.2% · $0.53/sh · 4.2% margin

Verdict: revenue grew 2.2% y/y to $2.21B, operating margin 8.2% vs 9.9%, net income $92M (+2.2% y/y).

Operating cash flow was $227 million and free cash flow was $144 million.

Source and notation

Source: Solventum press release, 8-K EX-99.1 of 08/05/2026 (SEC EDGAR). Every figure was matched against the income statement in the release and checked against SEC XBRL.

Open as an image: SOLV, Q2 2026 (PNG) ↗ · for sharing and presentations · free to reuse, CC BY 4.0

Cite / embed this chart

Free to use in articles, research and social posts with credit to Who Reports Today and a link — licensed under CC BY 4.0 (terms).

Credit line
Chart: “SOLV Q2 2026: where the revenue went” by Who Reports Today, https://whoreportstoday.com/t/solv/q2-2026. Licensed under CC BY 4.0.
HTML: image with link and credit
<figure>
  <a href="https://whoreportstoday.com/t/solv/q2-2026"><img src="https://whoreportstoday.com/t/solv/q2-2026/sankey.png" alt="SOLV Q2 2026: where the revenue went" loading="lazy" style="max-width:100%;height:auto"></a>
  <figcaption>Source: <a href="https://whoreportstoday.com/t/solv/q2-2026">Who Reports Today</a>, licensed under <a href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0</a></figcaption>
</figure>
Direct link to the image (PNG)
https://whoreportstoday.com/t/solv/q2-2026/sankey.png
Link for your article text
<a href="https://whoreportstoday.com/t/solv/q2-2026">SOLV Q2 2026 earnings chart (Who Reports Today)</a>

This is an archived report: the image at this link won’t change. If you change the chart (crop, translate), say so in the credit. Company logos and trademarks are not covered by the license.

SOLV — a healthcare company spun off from 3M that makes wound care, surgical, sterilization and infection-prevention products, dental and orthodontic products, and clinical documentation and coding software for hospitals, clinics and dental practices.

After selling its Purification & Filtration business to Thermo Fisher, it earns money in three segments: MedSurg (57.9% of 2025 sales), Dental Solutions and Health Information Systems. · Source: annual report (Form 10-K, SEC)

More reports: STE · Q2 FY2027 · SYK · Q3 2026 · TECH · Q1 FY2027 · TMO · Q3 2026 · UHS · Q3 2026 · UNH · Q3 2026 · VEEV · Q2 FY2027 · VRTX · Q3 2026 · VTRS · Q3 2026 · WAT · Q3 2026 · all reports

Company reports

Q3 2026latest breakdownTotal net sales fell 7.0% y/y to $1,949M
Q2 2026Revenue grew 2.2% y/y to $2.21B, operating margin 8.2% vs 9.9%, net income $92M (+2.2% y/y).

Cookies the site needs and, with your consent, Google Analytics — privacy policy